Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma.

Ther Adv Med Oncol · 2019 · PMC6557023 · PMID 31217827

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, CSPG4 overexpression showed a trend of correlation with a shorter overall survival (OS; Figure 1(c) ) and metastasis-free survival ( Figure 1(d) ) of OSA patients.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.